2015
DOI: 10.1080/09168451.2015.1008978
|View full text |Cite
|
Sign up to set email alerts
|

β-Thujaplicin modulates estrogen receptor signaling and inhibits proliferation of human breast cancer cells

Abstract: β-Thujaplicin, one of the major constituents in Chamaecyparis obtusa, has been demonstrated to exert different health beneficial efficacy, but the role of β-thujaplicin in regulating mammary tumorigenesis has not been investigated. In this study, we found that β-thujaplicin significantly suppressed the proliferation through arresting the cell cycle transition from G1 to S phase as well as inhibited the expression of cell cycle-related proteins, cyclin D1, and cyclin-dependent kinase 4 (CDK4) in MCF-7 and T47D … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 30 publications
0
9
0
Order By: Relevance
“…To validate our screening data,we performed second validation screening assay for the top candidates. Moreover, given the fact that HR occurs only in S and G2 phases of the cell cycle, HR levels are exquisitely sensitive to fluctuations in cell cycle progression, to demonstrate that β-thujaplicin’s HR inhibition effect is not due to the G1 or S arrest previously shown in other studies [33,38], we conducted the assays previously used in our own publication [22] to exclude cell cycle effects particularly the shift to G1 phase on HR repair by synchronizing cells using contact inhibition. As shown in Fig.…”
Section: Discussionmentioning
confidence: 79%
See 2 more Smart Citations
“…To validate our screening data,we performed second validation screening assay for the top candidates. Moreover, given the fact that HR occurs only in S and G2 phases of the cell cycle, HR levels are exquisitely sensitive to fluctuations in cell cycle progression, to demonstrate that β-thujaplicin’s HR inhibition effect is not due to the G1 or S arrest previously shown in other studies [33,38], we conducted the assays previously used in our own publication [22] to exclude cell cycle effects particularly the shift to G1 phase on HR repair by synchronizing cells using contact inhibition. As shown in Fig.…”
Section: Discussionmentioning
confidence: 79%
“…3A–C. We selected β-thujaplicin as our top candidate based on the marked suppression of HR of GFP, the existing literature reporting the biological activities and clinical usage safety of this potential candidate,and the most promising translational research potential [3335]. …”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Interestingly, β-thujaplicin down-regulated ERα expression, which led to cell growth inhibition. These results suggest that β-thujaplicin might be considered as a potent agent that regulates the hormone sensitive mammary tumorigenesis (Ko et al, 2015). …”
Section: Natural Xenoestrogensmentioning
confidence: 96%
“…Furthermore, β-thujaplicin (hinokiol), one of the constituents of C . obtusa essential oil, was recently reported to suppress proliferation of breast cancer cells [ 15 ] and have anti-inflammatory effects in mice [ 16 ].…”
Section: Introductionmentioning
confidence: 99%